First Time Loading...

Pharmicell Co Ltd
KRX:005690

Watchlist Manager
Pharmicell Co Ltd Logo
Pharmicell Co Ltd
KRX:005690
Watchlist
Price: 5 880 KRW -0.17% Market Closed
Updated: May 2, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Pharmicell Co Ltd

Wall Street analysts forecast Pharmicell Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Pharmicell Co Ltd is 17 500 KRW .

Lowest Forecast
Wall Street Target
Not Available
Average Forecast
Wall Street Target
17 500 KRW
198% Upside
Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
17 500 KRW
198% Upside
Highest
Price Target
Not Available
Pharmicell Co Ltd Competitors:
Price Targets
ARWR
Arrowhead Pharmaceuticals Inc
143% Upside
IONS
Ionis Pharmaceuticals Inc
32% Upside
ASND
Ascendis Pharma A/S
30% Upside
Y
002675
Yantai Dongcheng Biochemicals Co Ltd
50% Upside
ARWR
Arrowhead Pharmaceuticals Inc
143% Upside
IONS
Ionis Pharmaceuticals Inc
32% Upside
ASND
Ascendis Pharma A/S
30% Upside
Y
002675
Yantai Dongcheng Biochemicals Co Ltd
50% Upside
D
002030
Daan Gene Co Ltd
109% Upside
CRIS
Curis Inc
38% Upside
TRDA
Entrada Therapeutics Inc
62% Upside
VITR
Vitrolife AB
48% Upside

Revenue
Forecast

Revenue Estimate
Pharmicell Co Ltd

For the last 8 years the compound annual growth rate for Pharmicell Co Ltd's revenue is 11%. The projected CAGR for the next 1 year is 95%.

11%
Past Growth
95%
Estimated Growth
Estimates Accuracy
-9%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Pharmicell Co Ltd

The compound annual growth rate of Pharmicell Co Ltd's operating income for the next 1 year is 1 918%.

N/A
Past Growth
1 918%
Estimated Growth
Estimates Accuracy
-36%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Pharmicell Co Ltd

The compound annual growth rate of Pharmicell Co Ltd's net income for the next 1 year is 711%.

N/A
Past Growth
711%
Estimated Growth
Estimates Accuracy
-51%
Average Miss
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Pharmicell Co Ltd's stock price target?
Price Target
17 500 KRW

According to Wall Street analysts, the average 1-year price target for Pharmicell Co Ltd is 17 500 KRW .

What is Pharmicell Co Ltd's Revenue forecast?
Projected CAGR
95%

For the last 8 years the compound annual growth rate for Pharmicell Co Ltd's revenue is 11%. The projected CAGR for the next 1 year is 95%.

What is Pharmicell Co Ltd's Operating Income forecast?
Projected CAGR
1 918%

The compound annual growth rate of Pharmicell Co Ltd's operating income for the next 1 year is 1 918%.

What is Pharmicell Co Ltd's Net Income forecast?
Projected CAGR
711%

The compound annual growth rate of Pharmicell Co Ltd's net income for the next 1 year is 711%.

ALPHA SPREAD
Join more than 133,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.